Merril Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.73 M
as on 30-11-2024
- Paid Up Capital ₹ 4.01 M
as on 30-11-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.81 Cr
as on 30-11-2024
- Satisfied Charges ₹ 2.18 Cr
as on 30-11-2024
- Revenue 30.58%
(FY 2024)
- Profit 68.48%
(FY 2024)
- Ebitda 165.02%
(FY 2024)
- Net Worth -26.66%
(FY 2024)
- Total Assets 5.21%
(FY 2024)
About Merril Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.73 M and a paid-up capital of Rs 4.01 M.
The company currently has active open charges totaling ₹21.81 Cr. The company has closed loans amounting to ₹2.18 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jitendrakumar Raval, Rajendrasingh Jodha, Rajendrakumar Patel, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PTC046638
- Company No.
046638
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Merril Pharma Private Limited offer?
Merril Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Nutraceuticals & Dietary Supplements, Mineral Supplement, Health Conditions, Pain Relief.
Who are the key members and board of directors at Merril Pharma?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendrakumar Raval  | Director | 15-May-2006 | Current |
| Rajendrasingh Jodha | Director | 22-Aug-2005 | Current |
| Rajendrakumar Patel | Director | 15-May-2006 | Current |
| Rakeshkumar Patel | Director | 15-May-2006 | Current |
| Bharatkumar Patel | Director | 22-Aug-2005 | Current |
| Vipulkumar Patel | Director | 29-Jun-2007 | Current |
Financial Performance of Merril Pharma.
Merril Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30.58% increase. The company also saw a substantial improvement in profitability, with a 68.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 26.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merril Pharma?
In 2024, Merril Pharma had a promoter holding of 78.80% and a public holding of 21.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mestra Pharma Private LimitedActive 14 years 10 monthsJitendrakumar Raval, Rajendrasingh Jodha and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Mar 2022 | ₹8.99 M | Open |
Bank Of India Creation Date: 18 Dec 2020 | ₹14.00 Cr | Open |
Sidbi Creation Date: 29 Jul 2020 | ₹3.00 Cr | Open |
How Many Employees Work at Merril Pharma?
Merril Pharma has a workforce of 161 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merril Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merril Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
